Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Immedica Pharma AB

Closing information (x1000 SEK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 905,437 Less Arrow 609,582 Less Arrow 494,968
Financial expenses 71,279 More Arrow 77,172 Less Arrow 42,838
Earnings before taxes 83,576 Less Arrow 32,609 More Arrow 55,867
EBITDA 232,951 Less Arrow 186,814 More Arrow 208,139
Total assets 2,225,862 Less Arrow 1,537,992 Less Arrow 1,208,098
Current assets 586,907 Less Arrow 345,436 Less Arrow 314,844
Current liabilities 335,748 Less Arrow 169,468 Less Arrow 114,133
Equity capital 830,163 Less Arrow 659,251 Less Arrow 463,844
- share capital 50 Equal arrow 50 Equal arrow 50
Employees (average) 88 Less Arrow 69 Less Arrow 52

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 37.3% More Arrow 42.9% Less Arrow 38.4%
Turnover per employee 10,289 Less Arrow 8,835 More Arrow 9,519
Profit as a percentage of turnover 9.2% Less Arrow 5.3% More Arrow 11.3%
Return on assets (ROA) 7.0% More Arrow 7.1% More Arrow 8.2%
Current ratio 174.8% More Arrow 203.8% More Arrow 275.9%
Return on equity (ROE) 10.1% Less Arrow 4.9% More Arrow 12.0%
Change turnover 295,855 Less Arrow 114,614 Less Arrow 77,009
Change turnover % 49% Less Arrow 23% Less Arrow 18%
Chg. No. of employees 19 Less Arrow 17 Less Arrow 8
Chg. No. of employees % 28% More Arrow 33% Less Arrow 18%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.